# Chemed Corp: Form 10-Q for the period ended Mar 31, 2013

- Company: [Chemed Corp](/companies/che.md) (CIK 19584)
- Form: 10-Q
- Filed: 2013-04-26
- Accepted by EDGAR: Apr 26, 2013, 11:37 ET
- Period: 2013-03-31
- Accession: 0001157523-13-002063
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/19584/000115752313002063/a50614356.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/19584/000115752313002063/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2013-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2013-01-01 to 2013-03-31 | $366.6m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months, 2013-01-01 to 2013-03-31 | $264.3m | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months, 2013-01-01 to 2013-03-31 | $55.6m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2013-01-01 to 2013-03-31 | $38.9m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2013-01-01 to 2013-03-31 | $4.1m | us-gaap:InterestExpense |
| Income tax | 3 months, 2013-01-01 to 2013-03-31 | $14.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2013-01-01 to 2013-03-31 | $22.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2013-01-01 to 2013-03-31 | $1.17 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2013-01-01 to 2013-03-31 | $1.20 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2013-01-01 to 2013-03-31 | 19,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2013-01-01 to 2013-03-31 | $8.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2013-01-01 to 2013-03-31 | $5.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2013-01-01 to 2013-03-31 | $3.4m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | at 2013-03-31 | $73.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2013-03-31 | $236.2m | us-gaap:AssetsCurrent |
| Total assets | at 2013-03-31 | $899.4m | us-gaap:Assets |
| Current liabilities | at 2013-03-31 | $160.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2013-03-31 | $416.3m | us-gaap:Liabilities |
| Long-term debt | at 2013-03-31 | $177.0m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2013-03-31 | $483.1m | us-gaap:StockholdersEquity |
| Shares outstanding | at 2013-03-31 | 18,868,108 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/19584/000115752313002063/a50614356.htm

Filed Apr 26, 2013.
Source: SEC EDGAR, the filing index for accession 0001157523-13-002063. Last ingested by Listed: Nov 14, 2026, 12:29 ET. No prices; not investment advice.
